We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.79B
AUM Growth
+$164M
Cap. Flow
-$30.9M
Cap. Flow %
-1.11%
Top 10 Hldgs %
20.45%
Holding
3,380
New
284
Increased
506
Reduced
861
Closed
334

Top Buys

Rank Stock Value
1
AFL icon
Aflac
AFL
+$2.88M
2
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$2.53M
3
TRGP icon
Targa Resources
TRGP
+$2.39M
4
UNP icon
Union Pacific
UNP
+$2.39M
5
G icon
Genpact
G
+$2.13M

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Financials 10.71%
3 Consumer Discretionary 10.62%
4 Healthcare 9.54%
5 Industrials 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIVB
826
DELISTED
SVB Financial Group
SIVB
$420K 0.02%
754
GTLS
827
DELISTED
Chart Industries
GTLS
$419K 0.02%
2,864
-73
-2% -$10.7K
PEG icon
828
Public Service Enterprise Group
PEG
$37.8B
$418K 0.02%
6,990
CHRW icon
829
C.H. Robinson
CHRW
$17.1B
$416K 0.01%
4,452
WSC icon
830
WillScot Mobile Mini Holdings
WSC
$4B
$412K 0.01%
14,785
+695
+5% +$20K
INSP icon
831
Inspire Medical Systems
INSP
$1.68B
$411K 0.01%
2,129
BHVN
832
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$411K 0.01%
4,236
+206
+5% +$16.7K
MSTR icon
833
Strategy Inc
MSTR
$37.3B
$409K 0.01%
6,160
+210
+4% +$12.4K
RPD icon
834
Rapid7
RPD
$827M
$408K 0.01%
4,307
+101
+2% +$8.51K
BPMC
835
DELISTED
Blueprint Medicines
BPMC
$407K 0.01%
4,626
+125
+3% +$11.5K
KR icon
836
Kroger
KR
$34.3B
$404K 0.01%
10,537
AVB icon
837
AvalonBay Communities
AVB
$25.7B
$403K 0.01%
1,931
AMP icon
838
Ameriprise Financial
AMP
$49.9B
$402K 0.01%
1,616
EXE
839
Expand Energy Corp
EXE
$22.3B
$402K 0.01%
+7,748
New +$387K
NEO icon
840
NeoGenomics
NEO
$2.11B
$399K 0.01%
8,828
CBRE icon
841
CBRE Group
CBRE
$42.7B
$398K 0.01%
4,644
EFX icon
842
Equifax
EFX
$21.2B
$398K 0.01%
1,663
-107
-6% -$23.9K
TCOM icon
843
Trip.com Group
TCOM
$28.7B
$398K 0.01%
11,237
+198
+2% +$7.55K
EXPO icon
844
Exponent
EXPO
$3.22B
$394K 0.01%
4,423
-105
-2% -$9.83K
POWI icon
845
Power Integrations
POWI
$3.57B
$394K 0.01%
4,796
WST icon
846
West Pharmaceutical
WST
$24.8B
$394K 0.01%
1,098
-46
-4% -$15.2K
AJG icon
847
Arthur J. Gallagher & Co
AJG
$65.5B
$393K 0.01%
2,809
+11
+0.4% +$1.55K
TGTX icon
848
TG Therapeutics
TGTX
$7.58B
$393K 0.01%
10,140
+245
+2% +$9.62K
ITM icon
849
VanEck Intermediate Muni ETF
ITM
$2.13B
$390K 0.01%
7,544
+410
+6% +$21.2K
RBC icon
850
RBC Bearings
RBC
$17.6B
$387K 0.01%
1,940
-64
-3% -$12.6K

Similar funds

Ameritas Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Ameritas Investment Partners held 3,380 positions worth $2.79B, up 6.2% from $2.62B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Ameritas Investment Partners's Q2 2021 filing shows 284 new, 506 increased, 861 reduced and 334 closed positions. Its largest new stake was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M. The largest sale was Charles River Laboratories, an estimated $5.13M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2021 buy was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M.
  • Ameritas Investment Partners added most to Aflac in Q2 2021, an estimated $2.88M increase.
  • Ameritas Investment Partners's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $5.13M.
  • Ameritas Investment Partners fully exited TCF Financial Corporation Common Stock in Q2 2021, selling an estimated $1.96M.
  • Ameritas Investment Partners's ten largest holdings make up 20% of its $2.79B portfolio in Q2 2021.
  • Ameritas Investment Partners opened 284 new positions and closed 334 in Q2 2021.
  • Ameritas Investment Partners's portfolio value rose 6.2% quarter-over-quarter to $2.79B.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.